Patents by Inventor Maria Prat

Maria Prat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinuclidine carbamate derivatives and their use as M3 antagonists
    Publication number: 20040242629
    Abstract: A compound which is a carbamate of formula: 1
    Type: Application
    Filed: March 31, 2003
    Publication date: December 2, 2004
    Inventors: Maria Antonia Buil Albero, Dolors Fernandez Forner, Maria Prat Quinones
  • Novel quinuclidine derivatives and medicinal compositions containing the same
    Publication number: 20040132768
    Abstract: A compound according to formula (I) 1
    Type: Application
    Filed: December 17, 2003
    Publication date: July 8, 2004
    Inventors: Maria Dolors Fernandez Forner, Maria Prat Quinones, Maria Antonia Buil Albero
  • Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
    Patent number: 6750226
    Abstract: A compound according to formula (I) wherein: is a phenyl ring, a C4 to C9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; which shows high affinity for muscarinic M3 receptors (Hm3).
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: June 15, 2004
    Assignee: Almirall-Prodesfarma, S.A.
    Inventors: Dolors Fernandez Forner, Maria Prat Quiñones, Maria Antonia Buil Albero
  • Novel quinuclidine derivatives and medicinal compositions containing the same
    Publication number: 20040072863
    Abstract: A compound of formula (I), wherein B is a phenyl ring, a 5 to 10 membered heteroaromatic group containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl, benzo[1,3]dioxolyl, or biphenyl group; R1, R2 and R3 each independently represent a hydrogen or halogen atom, or a hydroxy group, a phenyl group, —OR7, —SR7, —NR7R8, —NHCOR7, —CONR7R8, —CN, —NO2, —COOR7 or CF3 group, or a strait or branched, substituted or unsubstituted lower alkyl group, wherein R7 and R8 each independently represent a hydrogen atom, a straight or branched lower alkyl group, or together form an alicyclic ring; or R1 and R2 together form an aromatic or alicyclic ring or a heterocyclic group.
    Type: Application
    Filed: December 8, 2003
    Publication date: April 15, 2004
    Inventors: Maria Prat Quinones, Maria Dolors Fernandez Forner, Maria Antonia Buil Albero
  • Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
    Publication number: 20030055080
    Abstract: A compound according to formula (I) 1
    Type: Application
    Filed: January 14, 2002
    Publication date: March 20, 2003
    Inventors: Dolors Fernandez Forner, Maria Prat Quinones, Maria Antonia Buil Albero
  • 1-aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharmaceutical composition
    Patent number: 5639904
    Abstract: The 1-aryloxy-3-alkylamino-2-propanol nitrate esters, having formula I: ##STR1## the enantiomers and diastereoisomers and the therapeutically acceptable salts thereof, wherein R.sub.1 is a chain of general formula II --(CH.sub.2).sub.m --Z--R.sub.2, where: m is 1 or 2; Z is an --O-- ether, --CONH amide or --COO-- ester function; and R.sub.2 is a C.sub.2-3 straight or branched chain alkyl having at least one nitroxy group as substituent; and Ar is a benzene ring when Z is the ether or ester function, and a naphthalene ring when Z is the amide function, are of use for the treatment of cardiovascular affections.
    Type: Grant
    Filed: August 11, 1995
    Date of Patent: June 17, 1997
    Assignee: Prodesfarma, S.A.
    Inventors: Maria Prat Quinones, Joan Pi Sallent, Dagmar Vedrilla Veit
  • Truncated forms of the hepatocyte growth factor (HGF) receptor
    Patent number: 5571509
    Abstract: A protein, which is useful as an antagonist of hepatocyte growth factor, is composed of two disulphide-linked chains of 50 kDa and 75 or 85 kDa respectively, the 5 kDa chain being the .alpha.-chain of the tyrosine kinase encoded by the MET protooncogene and the 75 or 85 kDa chain being a C-terminal truncated form of the .beta.-chain of the said tyrosine kinase.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: November 5, 1996
    Assignee: Farmitalia Carlo Erba S.R.L.
    Inventors: Paolo Comoglio, Tiziana Crepaldi, Maria Prat